MSU
ELOS

Mizuho Securities USA’s Syneron Medical Ltd ELOS Stock Holding History

Mizuho Securities USA’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-460,000
Closed -$5.04M – 267
2017
Q2 		$5.04M Buy
+460,000
New +$5.04M 0.26% 27

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Mizuho Securities USA's ELOS Position: Q3 2017 in Review

Mizuho Securities USA sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 460,000 shares — an estimated $5.04M sold.

Mizuho Securities USA first reported a position in ELOS in Q2 2017 and held it in 1 quarter. The position peaked at $5.04M in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Mizuho Securities USA reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Mizuho Securities USA sold 460,000 Syneron Medical Ltd shares in Q3 2017, an estimated $5.04M.
  • Mizuho Securities USA first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 1 quarter.
  • Mizuho Securities USA's Syneron Medical Ltd position peaked at $5.04M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Mizuho Securities USA's 13F filing for Q3 2017, filed 23 Oct 2017.